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Background and purpose   The Harris hip score (HHS), a dis-
ease-specific health status scale that is frequently used to measure 
the outcome of total hip arthroplasty, has never been validated 
properly. A questionnaire is suitable only when all 5 psychometric 
properties are of sufficient quality. We questioned the usefulness 
of the HHS by investigating its content validity. 
Methods   We performed a systematic review based on a lit-
erature search in PubMed, Embase, and the Cochrane Library 
for descriptive studies published in 2007. 54 studies (59 patient 
groups) met our criteria and were included in the data analysis. 
To determine the content validity, we calculated the ceiling effect 
(percentage) for each separate study and we pooled data to mea-
sure the weighted mean. A subanalysis of indications for THA was 
performed to differentiate the populations for which the HHS 
would be suitable and for which it would not. A ceiling effect of 
15% or less was considered to be acceptable.
Results   Over half the studies (31/59) revealed unacceptable 
ceiling effects. Pooled data across the studies included (n = 6,667 
patients) suggested ceiling effects of 20% (95%CI: 18–22). Ceiling 
effects were greater (32%, 95%CI:12–52) in those patients under-
going hip resurfacing arthroplasty. 
Interpretation   Although the Harris hip score is widely used 
in arthroplasty research on outcomes, ceiling effects are common 
and these severely limit its validity in this field of research. 
 
In evidence-based medicine, the use of clinically important 
patient outcomes in clinical research is paramount (Wright 
and Young 1997, Shi et al. 2009). Quality of life and func-
tion are usually measures that are important for patients and 
healthcare providers. The Harris hip score (HHS) is one such 
measure that has frequently been used to measure outcome 
after total hip arthroplasty (Haverkamp et al. 2008). 
Harris (1969) developed this score with a rating scale of 100 
points and with domains of pain, function, activity, deformity, 
and motion. It was designed for use in young men with often 
long-standing severe secondary osteoarthritis after a fracture 
of the acetabulum that was operated on with a Smith-Petersen 
vitallium mold arthroplasty. Although not originally designed 
for  hip  arthroplasty  (THA)  patients,  it  is  widely  used  for 
this population. Since its introduction, several authors have 
reported the score to be a valid outcome measure for THA 
based on good construct validity alone (Harris 1969, Soder-
man  and  Malchau  2001,  Shi  et  al.  2009). While  construct 
validity is important, it is not the sole factor in evaluating the 
overall validity of an outcome questionnaire. Reliability, inter-
nal consistency, content validity, and responsiveness are also 
important. A questionnaire is suitable only when all 5 psychometric 
properties are of sufficient quality (Terwee et al. 2007).
Content validity assesses the extent to which a metric mea-
sures all aspects of a certain phenomenon. The amount of ceil-
ing and floor effects present determine the quality of the con-
tent validity. A floor effect occurs when several of the patients 
score the lowest possible score, whereas a ceiling effect occurs 
when several of the patients score the highest possible score. 
Given the persistent use of the HHS in clinical research, we 
systemically reviewed clinical trials of primary hip arthroplasty 
using the HHS as an outcome measure. We hypothesized that 
ceiling effects are common, thereby limiting the validity of the 
HHS in arthroplasty outcome research. 
Methods
Our systematic review conformed to the PRISMA guidelines 
for reporting of meta-analyses and systematic reviews (Moher 
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Information sources and search
We performed a systematic review of the literature by per-
forming a computerized literature search in PubMed, Embase, 
and  the  Cochrane  Library  for  studies  published  in  2007, 
searching for “hip” and “arthroplasty” both as free text and as 
MESH terms. 
Eligibility criteria 
We included all descriptive trials, both prospective and ret-
rospective,  reporting  on  the  outcome  of  primary  total  hip 
arthroplasty. Our inclusion criteria for further analysis were: 
articles  published  in  English,  patients  undergoing  primary 
total hip arthroplasty, and a range (standard deviation) of the 
HHS score reported in the article. 
Study selection
2 of the authors (DH and KW) independently selected titles 
and  abstracts  for  possible  inclusion.  Full-text  manuscripts 
were retrieved for any abstracts that appeared potentially eli-
gible. The final decision to include a paper was based on a 
consensus between the 2 reviewers. 
The data collection process 
Data extraction was performed independently by the same 2 
authors (KW and DH), after which the data were compared 
and a consensus obtained. 
Calculation of ceiling effects 
Harris hip scores were reported as averages with SD or range. 
If no SD was given in the study, it was calculated from the 
range to estimate the percentage ceiling effect. A ceiling effect 
means that several patients score the highest possible score, 
thus they “reach the ceiling”. A ceiling effect is caused when 
the test items are not challenging enough for a group of indi-
viduals because the test has a limited number of difficult items 
or even an inappropriate item selection (McHorney and Tarlov 
1995). It will lead to a shortcoming in the discriminative abil-
ity of the test to detect clinically relevant changes; a person 
may continue to improve, but the test does not capture that 
improvement. A floor or ceiling effect of 15% is considered 
the maximum acceptable (Terwee et al. 2007).
Analysis
As described by Walter and Yao (2007), it is possible to esti-
mate the SD from a study when the mean and range and the 
size of the population is known. This method is widely used 
and accepted. We used it to estimate the SD for those stud-
ies where only the range and size (n) were given. In this data 
calculation, we assumed a normal distribution in the patient 
populations. This allowed us to estimate the percentage of 
ceiling effect present. This was calculated for each separate 
study, and data were also pooled to calculate a weighted over-
all percentage for all patients. 
We  performed  a  subgroup  analysis  based  on  the  indica-
tion for THA to assess whether the HHS would be suitable 
for  any  subgroup. Also,  a  subanalysis  for  the  influence  of 
age and length of follow-up on the content validity was per-
formed. Finally, we conducted a subgroup analysis evaluat-
ing ceiling effect in patients who underwent hip resurfacing 
arthroplasties. 
We report a descriptive analysis of the ceiling effects, as 
percentage with 95% confidence interval (CI). For analysis, 
we used the HHS score from the latest follow-up reported. A 
linear logistic regression was performed to search for factors 
influencing  the  percentage  ceiling  effect  (indication,  retro-
spective or prospective trial, average age, length of follow-up 
period, or type of procedure (hip resurfacing, minimally inva-
sive techniques, or normal THA). Statistical analyses were 
performed using SPSS software version 15.0. 
Results
Literature search
Of  764  potential  studies,  54  studies—of  which  59  groups 
could be reviewed (5 trials were comparative, describing 2 
populations;  altogether,  6,667  patients)—were  suitable  for 
inclusion. Figure shows the reasons for exclusion of certain 
studies. 45 studies reported primary THA for several indica-
tions, 13 of which focused on specific patient populations (4 
osteonecrosis, 9 dysplasia). Hip resurfacing was reported in 4 
studies. Details of each study included are given in the Table.
Ceiling effects
31/59 patient groups showed a ceiling effect greater than 15%. 
Pooling across the 59 patient groups showed a ceiling effect of 
20% (CI: 18–22). 
When studies needing a calculation of SD were excluded and 
only the 14 studies in which an SD was given were included, 
we found an average ceiling effect of 15.8% (4–30); 7 of the 
14 studies had a ceiling effect of more than 15%.
In the studies evaluating total hip arthroplasty in patients 
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Studies included 
Authors  Year   Group  Follow–up   n  Average  HHS  SD  Ceiling
      in years    HHS  range     effect (%)
Lim SJ et al.  2007  dysp  4.8  25  93.8   76–100  8.9  24
Kaneuji A et al.  2007  dysp  15.2  55  89   75–100  5.98  3
Incavo SJ et al.  2007  mix  6.7  143  91   63–100  10.64  20
Saito S et al.  2007  mix  6.4  76  95   91–100  1.89  1
Min BW et al.  2007  mix  7.7  98  92.9   83–99  b  0
Wangen H et al.  2007  dysp  13  49  88   62–100  11.44  15
León JL et al. #  2007  avn  2.9  24   a   a  a  0
Malizos KN et al.  2007  mix  5  245  94   69–97  b  0
Lin YC et al.  2007  mix  0.25  85  92   82–100  4.5 c  4
Zhang H et al.  2007  avn  1.9  72  92.4   78–100  6.05  10
Yates PJ et al.  2007  mix  11.1  122  86   47–100  15.6  18
Robinson RP  2007  mix  1  69  94   c  6 c  16
Robinson RP  2007  mix  1  92  92   c  11 c  23
Bragdon CR et al.  2007  mix  6.9  244  91.1   37–100  11.9 c  23
Flecher X et al.  2007  dysp  10.3  97  93   40–100  21.2  37
Le Duff MJ et al.  2007  mix  6.2  144  90.6   41–100  18.85  31
Le Duff MJ et al.  2007  mix  6.2  626  93.8   38–100  17.86  36
Lusty PJ et al.  2007  mix  6.5  259  95   61–100  11.56  33
Braun A et al.  2007  mix  6.5  37  91   33–100  27.3  37
Ochs U et al.  2007  mix  8.1  66  90.1   58.7–99.9  b  0
Kohler S et al.  2007  dysp  12.2  98  93   60–100  13.2  30
Leali A et al.  2007  mix  4.3  62  97   87–100  4.4  25
Hing CB et al.  2007  mix  3  227  95.2   47–100  16.39  38
Karatosun V et al.  2007  mix  3  71  93   64–100  12.18  28
Ender SA et al.  2007  mix  5  97  92   63–100  11.6  25
Vassan UT et al.  2007  mix  7  112  89   62–100  10.8  15
Kim YL et al.  2007  other  11  12  82.3   69–92  b  0
Lian YY et al.  2007  other  7.8  52  91.6   69–100  9.94  11
Parsch D et al.  2007  other  16  43  80   38–100  19.32  15
Guyen O et al.  2007  dysp  3.3  167  83.4   25–100  22.19  22
Akhavan S et al.  2007  dysp  6.2  99  98   86–100  4.8  34
Boyd HS et al.  2007  other  4.3  19  84   53–98  b  0
Fink B et al.  2007  mix  5.3  214  91.2   c  13.1 c  25
Isaac DL et al.  2007  mix  7.6  45  89   41–100  14.9 c  23
Lusty PJ et al.  2007  other  6.7  33  90   78–100  5.76  4
Baumann B et al.  2007  mix  9.5  69  85   c  13 c  12
Baumann B et al.  2007  mix  9.5  37  86   c  14c  18
Foucher KC et al.  2007  mix  1  28  95   61–100  17  38
Zhang XL et al.  2007  mix  1.5  27  94.5   92–96  b  0
Lachiewicz PF et al.  2007  mix  10.5  70  88   44–100  18.48  26
Mazoochian F et al.  2007  mix  7  10  94.4   85–100  4.1 c  9
Ito H et al.  2007  other  12  43  80.3   25–100  25.44  22
Nakamura Y et al.  2007  other  6.8  23  93.4   a  a  9
Yoon KS et al.  2007  mix  10.7  37  90   72–100  9.12  16
Yoon KS et al.  2007  mix  10.7  38  91   74–100  7.68  10
Cieliński Ł et al.  2007  mix  1  13  87.7   c  12 c  14
Kim YH et al.  2007  avn  11.2  194  91   59–100  11.52  22
Vidyadhara S et al.  2007  avn  4.1  45  96   c  3 c  9
Berend KR et al.  2007  mix  5  1080  88.3   c  8.3 c  8
Grübl A et al.  2007  mix  10  105  92   44–100  19.2  34
Kim KI et al.  2007  other  4.8  58  90   42–100  21.12  32
Harada Y et al.  2007  dysp  8.3  81  87.5   c  8.6 c  7
Jacob HA et al.  2007  mix  12  102  97   92–100  2.0  7
Ha YC et al.  2007  mix  5.5  74  94   82–100  5.04  12
Poggie RA et al.  2007  mix  1  157  93   51–100  15.96  33
Poggie RA et al.  2007  mix  1  315  92   36–100  19.04  34
Amstutz HC et al.  2007  dysp  6  59  92.5   41–100  22.66  37
Angin S et al.  2007  mix  3.8  8  95   82–100  9.5 c  30
Habermann B et al.  2006  other  11  15  89   76–100  7.49  7
a Described per patient.
b SD not calculated since range shows a ceiling effect of 0%. For instance, a range of 60–98 shows that 
the maximum score of 100 is not reached in this study; hence, the ceiling effect is 0%.
c SD given.
dysp: hip dysplasia; mix: mixed group; avn: avascular necrosis of femoral head, fracture, osteotomy. etc.706  Acta Orthopaedica 2010; 81 (6): 703–707
averaged 16% (CI: 8–24). Similarly, in patients with total hip 
arthroplasty for osteoarthritis secondary to dysplasia, the ceil-
ing effect averaged 24% (CI: 18–31). In patients treated with a 
hip resurfacing, the mean ceiling effect was 32% (CI: 12–52). 
Indication, study design, patient age, length of follow-up, 
and type of procedure had no statistically significant influence 
on the magnitude of the ceiling effect (p-values all > 0.05). 
Discussion
Key findings
Our  review  shows  that  the  Harris  hip  score  has  frequent 
ceiling effects in trials evaluating outcomes of primary hip 
arthroplasty, which indicates that it has limited application in 
exploration of treatment differences using newer techniques.
Strengths and limitations
Our meta-analysis has several strengths. We used a compre-
hensive systematic approach to identify relevant papers, we 
assessed the reliability of our assessments, and included a 
sufficient number of trials to be able to reach a conclusion. 
Finally,  our  systematic  review  followed  the  international 
PRISMA guidelines for reporting.
  Our  review  does  have  some  limitations.  We  calculated 
ceiling effect based on the assumption that scores in every 
population had a normal distribution. It is possible that nor-
mality was not met due to insufficient sample size, or merely 
because of the existence of the ceiling effect we were trying to 
investigate. However, in half of studies in which the SD was 
given rather than calculated by us, a ceiling effect was found. 
We determined only the ceiling effects and not floor effects 
because we believed that ceiling effects are the main limita-
tions of the Harris hip score (Soderman and Malchau 2001, 
Kirmit et al. 2005). None of the studies that investigated the 
reliability included the floor score in the range of distribution, 
while most included the ceiling value of 100. 
Previous literature
In 1969, when the HHS was developed, it probably had excel-
lent content validity due to the nature of the patient popula-
tion and type of implant at that time (Harris 1969). However, 
indications for joint replacement have expanded over time and 
improvements in implant designs and techniques have led to 
improved outcomes. The ability of a functional outcome mea-
sure to distinguish clinically relevant improvements in out-
comes with changes in prosthetic design is important. Ceil-
ing effects in an instrument can hide these differences when 
patients already score the maximum possible score and cannot 
improve on that score. For example, a 75-year-old patient just 
able to walk 2 hours at a normal pace would have the same 
score as a 45-year-old patient who has returned to running 
marathons.
Implications for future research
There are plenty of alternative scoring systems, including the 
WOMAC score, the Oxford 12-item questionnaire, and the 
HOOS (Roorda et al. 2004, Gosens et al. 2005, de Groot et al. 
2009). Ostendorf et al. (2004) evaluated the WOMAC score 
and the Oxford 12-item questionnaire for validity. The Oxford 
hip score did well in their study on all validity items. De Groot 
et al. (2009) evaluated the content validity of the Dutch ver-
sion  of  the  hip  disability  and  osteoarthritis  outcome  score 
(HOOS) and reported no ceiling effect and good validity. 
Besides having a problematic ceiling effect, HHS includes a 
physician’s physical examination component. Previous studies 
have shown that physical examination has a high intraobserver 
variablility (Poolman et al. 2009). Consequently, investigators 
have commonly used a modified Harris hip score without the 
physical examination part. Thus, the modified HHS suffers 
the drawbacks of ceiling effects as well as the problems of a 
non-validated modification of the original HHS score (Ragab 
2003). 
Conclusion
Based on our systematic review and meta-analysis, we con-
clude  that  the  Harris  hip  score  commonly  shows  ceiling 
effects, which limit its usefulness in trials evaluating the effi-
cacy of primary total hip arthroplasty. 
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